Experimental Hematology
Volume 36, Issue 1 , Pages 17-27 , January 2008

Hypoxia alters progression of the erythroid program

  • Heather M. Rogers

      Affiliations

    • Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md., USA
    • ,
  • Xiaobing Yu

      Affiliations

    • Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Md., USA
    • ,
  • Jie Wen

      Affiliations

    • Oral Immunity and Infection Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Md., USA
    • ,
  • Reginald Smith

      Affiliations

    • Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md., USA
    • ,
  • Eitan Fibach

      Affiliations

    • Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
    • ,
  • Constance Tom Noguchi

      Affiliations

    • Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md., USA
    • Corresponding Author InformationOffprint requests to: Constance Tom Noguchi, M.D., Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, MSC 1822, Building 10, Room 9N307, Bethesda, MD 20892-1822

Received 20 February 2007 ,Revised 24 July 2007 ,Accepted 8 August 2007.

References 

  1. Kaushansky K, Karplus PA. Hematopoietic growth factors: understanding functional diversity in structural terms. Blood. 1993;82:3229–3240
  2. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 1995;83:59–67
  3. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 1999;283:987–990
  4. Syed RS, Reid SW, Li C, et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature. 1998;395:511–516
  5. Remy I, Wilson IA, Michnick SW. Erythropoietin receptor activation by a ligand-induced conformation change. Science. 1999;283:990–993
  6. Bunn HF. New agents that stimulate erythropoiesis. Blood. 2007;109:868–873
  7. Tam BY, Wei K, Rudge JS, et al. VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med. 2006;12:793–800
  8. Ishikawa Y, Ito T. Kinetics of hemopoietic stem cells in a hypoxic culture. Eur J Haematol. 1988;40:126–129
  9. Cipolleschi MG, D'Ippolito G, Bernabei PA, et al. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro. Exp Hematol. 1997;25:1187–1194
  10. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858–864
  11. McAdams TA, Miller WM, Papoutsakis ET. pH is a potent modulator of erythroid differentiation. Br J Haematol. 1998;103:317–325
  12. Mizuno S, Glowacki J. Low oxygen tension enhances chondroinduction by demineralized bone matrix in human dermal fibroblasts in vitro. Cells Tissues Organs. 2005;180:151–158
  13. Lu L, Broxmeyer HE. Comparative influences of phytohemagglutinin-stimulated leukocyte conditioned medium, hemin, prostaglandin E, and low oxygen tension on colony formation by erythroid progenitor cells in normal human bone marrow. Exp Hematol. 1985;13:989–993
  14. Thomas ED, Lochte HL, Greenough WB, Wales M. In vitro synthesis of foetal and adult haemoglobin by foetal haematopoietic tissues. Nature. 1960;185:396–397
  15. Weinberg RS, Acosta R, Knobloch ME, Garber M, Alter BP. Low oxygen enhances sickle and normal erythropoiesis and fetal hemoglobin synthesis in vitro. Hemoglobin. 1995;19:263–275
  16. Narayan AD, Ersek A, Campbell TA, Colon DM, Pixley JS, Zanjani ED. The effect of hypoxia and stem cell source on haemoglobin switching. Br J Haematol. 2005;128:562–570
  17. Allen DW, Jandl JH. Factors influencing relative rates of synthesis of adult and fetal hemoglobin in vitro. J Clin Invest. 1960;39:1107–1113
  18. Fibach E. Techniques for studying stimulation of fetal hemoglobin production in human erythroid cultures. Hemoglobin. 1998;22:445–458
  19. Fibach E, Schechter AN, Noguchi CT, Rodgers GP. Reducing erythropoietin in cultures of human erythroid precursors elevates the proportion of fetal haemoglobin. Br J Haematol. 1994;88:39–45
  20. Yu X, Shacka JJ, Eells JB, et al. Erythropoietin receptor signalling is required for normal brain development. Development. 2002;129:505–516
  21. Smith RD, Li J, Noguchi CT, Schechter AN. Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells. Blood. 2000;95:863–869
  22. Jelkmann W. Molecular biology of erythropoietin. Intern Med. 2004;43:649–659
  23. Warnecke C, Zaborowska Z, Kurreck J, et al. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J. 2004;18:1462–1464
  24. Pace BS, Qian XH, Sangerman J, et al. p38 MAP kinase activation mediates gamma-globin gene induction in erythroid progenitors. Exp Hematol. 2003;31:1089–1096
  25. Papayannopoulou T, Nakamoto B, Agostinelli F, Manna M, Lucarelli G, Stamatoyannopoulos G. Fetal to adult hemopoietic cell transplantation in humans: insights into hemoglobin switching. Blood. 1986;67:99–104
  26. Alter BP. Fetal erythropoiesis in stress hematopoiesis. Exp Hematol. 1979;7(Suppl 5):200–209
  27. Papayannopoulou T, Vichinsky E, Stamatoyannopoulos G. Fetal Hb production during acute erythroid expansion. I. Observations in patients with transient erythroblastopenia and post-phlebotomy. Br J Haematol. 1980;44:535–546
  28. Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol. 2005;33:259–271
  29. Jelkmann W, Wagner K. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann Hematol. 2004;83:673–686
  30. Palstra RJ, Tolhuis B, Splinter E, Nijmeijer R, Grosveld F, de Laat W. The beta-globin nuclear compartment in development and erythroid differentiation. Nat Genet. 2003;35:190–194
  31. Im H, Grass JA, Johnson KD, et al. Chromatin domain activation via GATA-1 utilization of a small subset of dispersed GATA motifs within a broad chromosomal region. Proc Natl Acad Sci U S A. 2005;102:17065–17070
  32. Vakoc CR, Letting DL, Gheldof N, et al. Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1. Mol Cell. 2005;17:453–462
  33. Zhang W, Kadam S, Emerson BM, Bieker JJ. Site-specific acetylation by p300 or CREB binding protein regulates erythroid Kruppel-like factor transcriptional activity via its interaction with the SWI-SNF complex. Mol Cell Biol. 2001;21:2413–2422
  34. Ravet E, Reynaud D, Titeux M, et al. Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis. Blood. 2004;103:3326–3335
  35. Ikonomi P, Noguchi CT, Miller W, Kassahun H, Hardison R, Schechter AN. Levels of GATA-1/GATA-2 transcription factors modulate expression of embryonic and fetal hemoglobins. Gene. 2000;261:277–287
  36. Martowicz ML, Grass JA, Boyer ME, Guend H, Bresnick EH. Dynamic GATA factor interplay at a multicomponent regulatory region of the GATA-2 locus. J Biol Chem. 2005;280:1724–1732
  37. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood. 2004;104:2073–2080
  38. Maxwell PH. Hypoxia-inducible factor as a physiological regulator. Exp Physiol. 2005;90:791–797
  39. Liu L, Cash TP, Jones RG, Keith B, Thompson CB, Simon MC. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell. 2006;21:521–531
  40. Emerling BM, Platanias LC, Black E, Nebreda AR, Davis RJ, Chandel NS. Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol Cell Biol. 2005;25:4853–4862
  41. Caro J, Brown S, Miller O, et al. Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med. 1979;93:449–458

PII: S0301-472X(07)00522-X

doi: 10.1016/j.exphem.2007.08.014

Experimental Hematology
Volume 36, Issue 1 , Pages 17-27 , January 2008

Article Tools

* Image Usage & Resolution